{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T22:23:13Z","timestamp":1794090193000,"version":"4.8.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.antiviral.2026.106549","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:46:22Z","timestamp":1791992782000},"page":"106549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Meeting report: 39th International Conference on Antiviral Research in Prague, Czech Republic, April 27\u2013May 1, 2026"],"prefix":"10.1016","volume":"255","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6678-1976","authenticated-orcid":false,"given":"Robert","family":"Jordan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7938-0389","authenticated-orcid":false,"given":"Nancie M.","family":"Archin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Barclay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9728-3419","authenticated-orcid":false,"given":"Andrea","family":"Brancale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5597-334X","authenticated-orcid":false,"given":"Valeria","family":"Cagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda","family":"Cardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8874-675X","authenticated-orcid":false,"given":"Leen","family":"Delang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8299-3787","authenticated-orcid":false,"given":"Joana","family":"Rocha-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4837-1911","authenticated-orcid":false,"given":"Joy Y.","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Gentry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5661-9828","authenticated-orcid":false,"given":"Lara J.","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0578-7765","authenticated-orcid":false,"given":"Branka","family":"Horvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4654-679X","authenticated-orcid":false,"given":"Zlatko","family":"Janeba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radim","family":"Nencka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Julander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny G.","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4655-2380","authenticated-orcid":false,"given":"Daniel","family":"Ruzek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5789-8590","authenticated-orcid":false,"given":"Luis M.","family":"Schang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0154-3459","authenticated-orcid":false,"given":"Katherine L.","family":"Seley-Radtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9181-2183","authenticated-orcid":false,"given":"Timothy P.","family":"Sheahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R.","family":"Spengler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Tavis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viet Loan","family":"Dao Thi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2799-7352","authenticated-orcid":false,"given":"Jan","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6905-8521","authenticated-orcid":false,"given":"Stephen R.","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Durantel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2026.106549_bib1","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.ajt.2024.07.002","article-title":"Nonclinical and clinical characterization of MAU868, a novel human-derived monoclonal neutralizing antibody targeting BK polyomavirus VP1","volume":"24","author":"Abend","year":"2024","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.antiviral.2026.106549_bib2","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210236","article-title":"Broad and potent neutralizing human antibodies to tick-borne flaviviruses protect mice from disease","volume":"218","author":"Agudelo","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2026.106549_bib3","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1007\/s12015-026-11061-4","article-title":"Human Myelin spheres for in vitro oligodendrocyte maturation, myelination and neurological disease modeling","volume":"22","author":"Ahuja","year":"2026","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.antiviral.2026.106549_bib4","author":"Akkermans"},{"key":"10.1016\/j.antiviral.2026.106549_bib5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.antiviral.2017.07.017","article-title":"Highlights of the 30th international conference on antiviral research","volume":"145","author":"Andrei","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106549_bib6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1039\/C3FD00139C","article-title":"Haptic-driven, interactive drug design: implementing a GPU-based approach to evaluate the induced fit effect","volume":"169","author":"Anthopoulos","year":"2014","journal-title":"Faraday Discuss."},{"key":"10.1016\/j.antiviral.2026.106549_bib9","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2314134","article-title":"Bulevirtide combined with pegylated interferon for chronic hepatitis D","author":"Asselah","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2026.106549_bib10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11095-018-2362-0","article-title":"Human primary cell-based Organotypic microtissues for modeling small intestinal drug absorption","volume":"35","author":"Ayehunie","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.antiviral.2026.106549_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.antiviral.2013.01.002","article-title":"Computer-aided identification, design and synthesis of a novel series of compounds with selective antiviral activity against chikungunya virus","volume":"98","author":"Bassetto","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106549_bib12","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2025.2542246","article-title":"Three-dimensional mapping of tick-borne encephalitis virus distribution in the mouse brain using a newly engineered TurboGFP reporter virus","volume":"14","author":"Berankova","year":"2025","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.antiviral.2026.106549_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/20402066221130853","article-title":"Meeting report: 34th international conference on antiviral research","volume":"30","author":"Brancale","year":"2022","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/j.antiviral.2026.106549_bib14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.antiviral.2018.08.002","article-title":"Meeting report: 31st international conference on antiviral research","volume":"158","author":"Bray","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106549_bib15","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1183\/23120541.01283-2025","article-title":"Donor-derived airway air\u2013liquid interface model for high-throughput screening of antiviral combinations with concurrent analysis of antiviral efficacy and epithelial toxicity using ciliR","volume":"12","author":"Cardinale","year":"2026","journal-title":"ERJ Open Res."},{"key":"10.1016\/j.antiviral.2026.106549_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2026.106402","article-title":"Preclinical efficacy of a favipiravir and nitazoxanide combination against Rift valley fever virus","volume":"249","author":"Chaput","year":"2026","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106549_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29622","article-title":"Viral RNA capping: mechanisms and antiviral therapy","volume":"96","author":"Chen","year":"2024","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2026.106549_bib18","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1073\/pnas.0808790106","article-title":"Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase","volume":"106","author":"Chen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2026.106549_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002294","article-title":"Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2\u2032-O-Methylation by nsp16\/nsp10 protein complex","volume":"7","author":"Chen","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2026.106549_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110890","article-title":"A split luciferase system for studying coronavirus Mpro dimerization in vitro and in living cells","volume":"301","author":"Delgado","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2026.106549_bib21","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1056\/NEJMoa2500179","article-title":"Daily Mosnodenvir as dengue prophylaxis in a controlled human infection model","volume":"393","author":"Durbin","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2026.106549_bib22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2023.05.001","article-title":"EASL clinical practice guidelines on hepatitis delta virus","volume":"79","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2026.106549_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01028-17","article-title":"Escape of tick-borne flavivirus from 2\u2019-C-Methylated nucleoside antivirals is mediated by a single conservative mutation in NS5 that has a dramatic effect on viral fitness","volume":"91","author":"Eyer","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106549_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00367-19","article-title":"An E460D substitution in the NS5 protein of tick-borne encephalitis virus confers resistance to the inhibitor Galidesivir (BCX4430) and also attenuates the virus for mice","volume":"93","author":"Eyer","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106549_bib25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejmech.2018.02.054","article-title":"Rational modifications on a benzylidene-acrylohydrazide antiviral scaffold, synthesis and evaluation of bioactivity against Chikungunya virus","volume":"149","author":"Giancotti","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.antiviral.2026.106549_bib26","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41586-023-05790-6","article-title":"Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates","volume":"615","author":"Goethals","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2026.106549_bib27","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.apsb.2025.03.011","article-title":"Overview of host-directed antiviral targets for future research and drug development","volume":"15","author":"Gu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.antiviral.2026.106549_bib28","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1038\/s41467-023-41476-3","article-title":"Creating resistance to avian influenza infection through genome editing of the ANP32 gene family","volume":"14","author":"Idoko-Akoh","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2026.106549_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2025.106222","article-title":"Meeting report: 38th international conference on antiviral research in Las Vegas, United States of America, March 17-21, 2025","volume":"241","author":"Jordan","year":"2025","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106549_bib31","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41586-021-03990-6","article-title":"A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction","volume":"598","author":"Kaptein","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2026.106549_bib32","doi-asserted-by":"crossref","first-page":"8106","DOI":"10.1038\/s41467-024-51952-z","article-title":"Alphavirus nsP3 organizes into tubular scaffolds essential for infection and the cytoplasmic granule architecture","volume":"15","author":"Kril","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2026.106549_bib33","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1126\/science.abi9310","article-title":"Structural basis of mismatch recognition by a SARS-CoV-2 proofreading enzyme","volume":"373","author":"Liu","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2026.106549_bib34","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1038\/s41467-024-46706-w","article-title":"Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2026.106549_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120668","article-title":"3D scaffold-free microlivers with drug metabolic function generated by lineage-reprogrammed hepatocytes from human fibroblasts","volume":"269","author":"Lu","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.antiviral.2026.106549_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s44298-026-00194-5","article-title":"A robust cell-based infection model for Rhinovirus C research and antiviral drug discovery","author":"Lyoo","year":"2026","journal-title":"npj Virus."},{"key":"10.1016\/j.antiviral.2026.106549_bib37","author":"Macleod"},{"key":"10.1016\/j.antiviral.2026.106549_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.106003","article-title":"Bithiazole inhibitors of PI4KB show broad-spectrum antiviral activity against different viral families","volume":"231","author":"Martina","year":"2024","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106549_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2026.119080","article-title":"Identification of 3-cyanoquinolines as broad-spectrum inhibitors of Monkeypox virus and other sexually transmitted pathogens","volume":"196","author":"Martina","year":"2026","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.antiviral.2026.106549_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adv9311","article-title":"A pan-respiratory virus attachment inhibitor with high potency in human airway models and in vivo","volume":"11","author":"Mathez","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.antiviral.2026.106549_bib41","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1021\/jm301778x","article-title":"Novel antiviral activity of l-dideoxy bicyclic nucleoside analogues versus vaccinia and measles viruses in vitro","volume":"56","author":"McGuigan","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2026.106549_bib42","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B","volume":"64","author":"Nassal","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2026.106549_bib43","article-title":"BK polyomavirus infection in kidney transplantation: a comprehensive review of current challenges and future directions","volume":"25","author":"Nourie","year":"2024","journal-title":"IJMS"},{"key":"10.1016\/j.antiviral.2026.106549_bib44","author":"Ohashi"},{"key":"10.1016\/j.antiviral.2026.106549_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03662-21","article-title":"N7-Methylation of the coronavirus RNA cap is required for maximal virulence by preventing innate immune recognition","volume":"13","author":"Pan","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2026.106549_bib46","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.celrep.2020.01.026","article-title":"Transcriptional correlates of tolerance and lethality in mice predict Ebola virus disease patient outcomes","volume":"30","author":"Price","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.antiviral.2026.106549_bib47","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.chembiol.2026.02.003","article-title":"Influenza A virus polymerase co-opts distinct sets of host proteins for RNA transcription or replication","volume":"33","author":"Rasmussen","year":"2026","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.antiviral.2026.106549_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/science.1259595","article-title":"Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance","volume":"346","author":"Rasmussen","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2026.106549_bib49","first-page":"545","article-title":"A global scientific strategy to cure hepatitis B. The lancet","volume":"4","author":"Revill","year":"2019","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2026.106549_bib50","doi-asserted-by":"crossref","first-page":"8953","DOI":"10.1038\/s41598-020-65832-1","article-title":"A simple and scalable strategy for analysis of endogenous protein dynamics","volume":"10","author":"Schwinn","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2026.106549_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2026.106418","article-title":"Receptor recognition of hepatitis B and D viruses: structural insight and its application to drug discovery","volume":"250","author":"Shionoya","year":"2026","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106549_bib52","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.antiviral.2017.11.019","article-title":"Second international conference on Crimean-Congo hemorrhagic fever","volume":"150","author":"Spengler","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106549_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105678","article-title":"Meeting report: 36th international conference on antiviral research in Lyon, France - march 13-17, 2023","volume":"217","author":"Spengler","year":"2023","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106549_bib54","article-title":"Meeting report: 35th international conference on antiviral research in Seattle, Washington, USA - march 21-25, 2022","volume":"211","author":"Spengler","year":"2022","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106549_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2022.101279","article-title":"Nucleoside analogs for management of respiratory virus infections: mechanism of action and clinical efficacy","volume":"57","author":"Stevaert","year":"2022","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2026.106549_bib56","author":"Super"},{"key":"10.1016\/j.antiviral.2026.106549_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113149","article-title":"A combination of two resistance mechanisms is critical for tick-borne encephalitis virus escape from a broadly neutralizing human antibody","volume":"42","author":"Svoboda","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.antiviral.2026.106549_bib58","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/ilar.52.1.24","article-title":"The collaborative cross: a recombinant inbred mouse population for the systems genetic era","volume":"52","author":"Threadgill","year":"2011","journal-title":"ILAR J."},{"key":"10.1016\/j.antiviral.2026.106549_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104550","article-title":"Meeting report: 32nd international conference on antiviral research","volume":"169","author":"Tramontano","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106549_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012571","article-title":"A guanidine-based coronavirus replication inhibitor which targets the nsp15 endoribonuclease and selects for interferon-susceptible mutant viruses","volume":"21","author":"Van Loy","year":"2025","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2026.106549_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105921","article-title":"The coronavirus nsp15 endoribonuclease: a puzzling protein and pertinent antiviral drug target","volume":"228","author":"Van Loy","year":"2024","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106549_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105452","article-title":"Geneticin shows selective antiviral activity against SARS-CoV-2 by interfering with programmed \u22121 ribosomal frameshifting","volume":"208","author":"Varricchio","year":"2022","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106549_bib64","first-page":"512","article-title":"Antiviral Research--16th international conference: 27 April-1 May 2003, Savannah, GA, USA","volume":"6","author":"Vere Hodge","year":"2003","journal-title":"Idrugs : Investig. Drugs J."},{"key":"10.1016\/j.antiviral.2026.106549_bib65","first-page":"515","article-title":"Antiviral Research--16th annual international conference. Satellite symposium: clinical update on antiviral drugs. 27 April-1 May 2003, Savannah, GA, USA","volume":"6","author":"Vere Hodge","year":"2003","journal-title":"Idrugs : Investig. Drugs J."},{"key":"10.1016\/j.antiviral.2026.106549_bib63","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3851\/IMP1885","article-title":"Scientific report: highlights of 24th ICAR, 8-11 May 2011, Sofia, Bulgaria","volume":"22","author":"Vere Hodge","year":"2011","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2026.106549_bib69","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.antiviral.2013.08.006","article-title":"Meeting report: 26th international conference on antiviral research","volume":"100","author":"Vere Hodge","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106549_bib68","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.antiviral.2014.08.009","article-title":"Meeting report: 27th international conference on antiviral research, in Raleigh, NC, USA","volume":"111","author":"Vere Hodge","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106549_bib67","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.antiviral.2015.09.015","article-title":"Meeting report: 28th international conference on antiviral research in Rome, Italy","volume":"123","author":"Vere Hodge","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106549_bib66","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2016.10.014","article-title":"Meeting report: 29th International Conference on Antiviral Research in La Jolla, CA, USA","volume":"137","author":"Vere Hodge","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106549_bib70","doi-asserted-by":"crossref","first-page":"e1074","DOI":"10.1093\/cid\/ciaa1840","article-title":"Higher plasma viremia in the febrile phase is associated with adverse dengue outcomes irrespective of infecting serotype or host immune status: an analysis of 5642 Vietnamese cases","volume":"72","author":"Vuong","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2026.106549_bib71","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41579-024-01121-2","article-title":"Hepatitis B and D virus entry","volume":"23","author":"Watashi","year":"2025","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2026.106549_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013122","article-title":"A highly potent human antibody neutralizing all serotypes of BK polyomavirus","volume":"21","author":"Weber","year":"2025","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2026.106549_bib73","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa2213429","article-title":"A phase 3, randomized trial of bulevirtide in chronic hepatitis D","volume":"389","author":"Wedemeyer","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2026.106549_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.106037","article-title":"Meeting report of the 37th international conference on antiviral research in Gold Coast, Australia, May 20-24, 2024, organized by the international society for antiviral research","volume":"232","author":"Welch","year":"2024","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106549_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012216","article-title":"Identification and characterization of three monoclonal antibodies targeting the SFTSV glycoprotein and displaying a broad spectrum recognition of SFTSV-related viruses","volume":"18","author":"Wu","year":"2024","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2026.106549_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012550","article-title":"Molecular mechanism and structure-guided humanization of a broadly neutralizing antibody against SFTSV","volume":"20","author":"Yang","year":"2024","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2026.106549_bib77","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2519755122","article-title":"Molecular basis of SARS-CoV-2 proofreading enzyme\u2013mediated resistance to remdesivir","volume":"122","author":"Yang","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2026.106549_bib78","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1038\/s41564-025-02168-4","article-title":"Structural and mechanistic insights into herpesvirus helicase\u2013primase and its therapeutic inhibitors","volume":"10","author":"Yao","year":"2025","journal-title":"Nat. Microbiol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354226002081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354226002081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T21:24:22Z","timestamp":1794086662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354226002081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":75,"alternative-id":["S0166354226002081"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2026.106549","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meeting report: 39th International Conference on Antiviral Research in Prague, Czech Republic, April 27\u2013May 1, 2026","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2026.106549","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106549"}}